Skip to main navigation Skip to search Skip to main content

Performance of diagnostic procedures for bubonic plague in endemic settings in Madagascar: a prospective test accuracy sub-study within the IMASOY trial

  • Mihaja Raberahona
  • , Minoarisoa Rajerison
  • , Tansy Edwards
  • , Josephine Bourner
  • , Elise Pesonel
  • , Beza Ramasindrazana
  • , Salohiniana Manuel Randriamanantena
  • , Voahangy Andrianaivoarimanana
  • , Lisy Hanitra Razananaivo
  • , Gabriella Zadonirina
  • , Theodora Mayouya-Gamana
  • , Reziky Tiandraza Mangahasimbola
  • , Mamy Randria
  • , Rivonirina Andry Rakotoarivelo
  • , Peter Horby
  • , Rindra Vatosoa Randremanana
  • , Piero Olliaro
  • Hôpital Joseph Raseta Befelatanana
  • Equipe de Recherche Clinique en Maladies Infectieuses (ERCMI)
  • Université d'Antananarivo
  • Institut Pasteur de Madagascar
  • London School of Hygiene and Tropical Medicine
  • University of Oxford
  • Université de Fianarantsoa
  • University Hospital Tambohobe

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives We aimed to assess the diagnostic value of a battery of confirmatory tests included in the WHO guidelines for bubonic plague, combined and individually, including culture, PCR and serology, and the on-site and laboratory performance of the F1 antigen-based lateral flow rapid diagnostic test (F1RDT). 

Methods Bubo aspirates from patients (all ages) with suspected bubonic plague enrolled into the IMASOY trial (NCT04110340) underwent routine laboratory diagnosis complemented with serology to measure IgG F1 antibodies from blood samples taken on days 1, 11, and 21. The performance of the F1RDT done on site (on-site F1RDT) and at the Central Laboratory for Plague (reference laboratory F1RDT) was compared against two reference standards: RS1 (culture or PCR-positive), which is used in routine practice, and RS2 (RS1 and serology-positive), including all available confirmatory tests for plague. Results Of 438 suspected cases, 184 (42%) were confirmed by culture or PCR (RS1) and 211 (48%) by culture, PCR, or serology (RS2). PCR identified 179 cases (85%), culture 137 (65%), and serology 197 (93%). The combination of PCR and culture identified 87% of confirmed cases while the remaining 13% were identified by serology only. The sensitivity and specificity of on-site F1RDT were 94% (95% CI, 89.6–97.0) and 74% (95% CI, 68.2–79.3) against RS1 and 89.1% (95% CI, 84.1–93) and 77.5% (95% CI, 71.5–82.8) against RS2. The sensitivity and specificity of reference laboratory F1RDT were 91.8% (95% CI, 86.9–95.4), 97.6% (95% CI, 94.9–99.1) against RS1, and 82.0% (95% CI, 76.1–86.9) and 99.1% (95% CI, 96.9–99.9) against RS2. Conclusions PCR outperforms culture, the previous reference standard. While serology adds diagnostic value, it is impractical for routine use. The F1RDT done on site cannot be relied upon for clinical case management decisions. F1RDT performs better under laboratory conditions and could be implemented in peripheral laboratories for surveillance purposes in resource-constraint settings.

Original languageEnglish
Pages (from-to)638-643
Number of pages6
JournalClinical Microbiology and Infection
Volume32
Issue number4
Early online date11 Dec 2025
DOIs
Publication statusE-pub ahead of print - 11 Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Culture
  • Diagnosis
  • F1 antigen
  • F1RDT
  • Microbiology
  • Plague
  • Polymerase chain reaction
  • Rapid diagnostic test
  • Serology
  • Yersinia pestis

Fingerprint

Dive into the research topics of 'Performance of diagnostic procedures for bubonic plague in endemic settings in Madagascar: a prospective test accuracy sub-study within the IMASOY trial'. Together they form a unique fingerprint.

Cite this